Accord Healthcare launches Disulfiram for treatment of alcoholism

Accord Healthcare UK Ltd has announced that Disulfiram, an alcohol deterrent compound, will be made available to all UK pharmacists and dispensing doctors for prescription to suitable patients.

Following its launch to wholesalers in December 2024, the medication will now be accessible for the treatment of alcohol dependence under appropriate medical supervision.

Disulfiram is indicated as an adjuvant in the treatment of carefully selected and co-operative patients with drinking problems.

The medication works by inhibiting the enzyme responsible for breaking down acetaldehyde—a substance produced when alcohol is metabolised in the body.

This results in a buildup of acetaldehyde in the blood, triggering unpleasant reactions such as headaches, heart palpitations, and nausea. The experience of such reactions acts as a deterrent to further alcohol intake.